Frequency
Latest
OSIP
Headlines
The company announces results of a crucial phase II study of the experimental cancer drug.
10:15AM 12/08/08
These heavily shorted biotech stocks could surge on any positive catalyst.
11:49AM 11/21/08
OSI Pharmaceuticals is up 5.7%.
3:55PM 11/19/08
GenVec's shares sank Wednesday despite what the company said was a positive update on its experimental pancreatic cancer drug TNFerad.
1:40PM 11/19/08
Amylin is down 20.1%.
3:57PM 11/12/08
Accuray falls 16%.
5:16PM 11/07/08
Sanofi-Aventis climbs, while Amylin falls.
3:37PM 10/28/08
Biotech stocks were falling along with the broader market Monday, but confirmation of Eli Lilly's bid lifted ImClone shares.
1:28PM 10/06/08
Genentech and OSI Pharmaceuticals said a late-stage study testing the combination use of Avastin and Tarceva failed to increase overall survival rates.
9:29AM 10/06/08
Exelixis slips lower on a soon-to-end collaboration with Glaxo.
4:19PM 06/27/08
Understanding the Market
Our Experts' Take at RealMoney for OSI Pharmaceuticals Inc.
Traders are cycling back into 'slow motion' stocks and realizing that they oversold Wal-Mart.
12:39PM 01/09/09
Once again, sentiment is in the driver's seat.
8:58AM 01/09/09
More Experts' Takes on OSIP
More popular tickers are indicated by scale.